Why the former X CEO is pushing GLP-1s to transform healthcare

AI Briefing

• – Former X CEO Linda Yaccarino is exploring health tech and the growth of GLP-1 medications.
• – GLP-1 medications have shown promising results in treating type 2 diabetes and are gaining traction in the healthcare industry.
• – Yaccarino's entry into health tech follows a career in the telecom industry.